These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 1748302

  • 1. Cloning of an activated human ret gene with a novel 5' sequence fused by DNA rearrangement.
    Kunieda T, Matsui M, Nomura N, Ishizaki R.
    Gene; 1991 Nov 15; 107(2):323-8. PubMed ID: 1748302
    [Abstract] [Full Text] [Related]

  • 2. Molecular characterization of RET/PTC3; a novel rearranged version of the RETproto-oncogene in a human thyroid papillary carcinoma.
    Santoro M, Dathan NA, Berlingieri MT, Bongarzone I, Paulin C, Grieco M, Pierotti MA, Vecchio G, Fusco A.
    Oncogene; 1994 Feb 15; 9(2):509-16. PubMed ID: 8290261
    [Abstract] [Full Text] [Related]

  • 3. PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas.
    Grieco M, Santoro M, Berlingieri MT, Melillo RM, Donghi R, Bongarzone I, Pierotti MA, Della Porta G, Fusco A, Vecchio G.
    Cell; 1990 Feb 23; 60(4):557-63. PubMed ID: 2406025
    [Abstract] [Full Text] [Related]

  • 4. Molecular characterization of a thyroid tumor-specific transforming sequence formed by the fusion of ret tyrosine kinase and the regulatory subunit RI alpha of cyclic AMP-dependent protein kinase A.
    Bongarzone I, Monzini N, Borrello MG, Carcano C, Ferraresi G, Arighi E, Mondellini P, Della Porta G, Pierotti MA.
    Mol Cell Biol; 1993 Jan 23; 13(1):358-66. PubMed ID: 7678053
    [Abstract] [Full Text] [Related]

  • 5. Cloning and expression of the ret proto-oncogene encoding a tyrosine kinase with two potential transmembrane domains.
    Takahashi M, Buma Y, Iwamoto T, Inaguma Y, Ikeda H, Hiai H.
    Oncogene; 1988 Nov 23; 3(5):571-8. PubMed ID: 3078962
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The full oncogenic activity of Ret/ptc2 depends on tyrosine 539, a docking site for phospholipase Cgamma.
    Borrello MG, Alberti L, Arighi E, Bongarzone I, Battistini C, Bardelli A, Pasini B, Piutti C, Rizzetti MG, Mondellini P, Radice MT, Pierotti MA.
    Mol Cell Biol; 1996 May 23; 16(5):2151-63. PubMed ID: 8628282
    [Abstract] [Full Text] [Related]

  • 9. Frequent activation of ret protooncogene by fusion with a new activating gene in papillary thyroid carcinomas.
    Bongarzone I, Butti MG, Coronelli S, Borrello MG, Santoro M, Mondellini P, Pilotti S, Fusco A, Della Porta G, Pierotti MA.
    Cancer Res; 1994 Jun 01; 54(11):2979-85. PubMed ID: 8187085
    [Abstract] [Full Text] [Related]

  • 10. Oncogenic rearrangements of the RET proto-oncogene in papillary thyroid carcinomas from children exposed to the Chernobyl nuclear accident.
    Fugazzola L, Pilotti S, Pinchera A, Vorontsova TV, Mondellini P, Bongarzone I, Greco A, Astakhova L, Butti MG, Demidchik EP.
    Cancer Res; 1995 Dec 01; 55(23):5617-20. PubMed ID: 7585643
    [Abstract] [Full Text] [Related]

  • 11. cDNA cloning of mouse ret proto-oncogene and its sequence similarity to the cadherin superfamily.
    Iwamoto T, Taniguchi M, Asai N, Ohkusu K, Nakashima I, Takahashi M.
    Oncogene; 1993 Apr 01; 8(4):1087-91. PubMed ID: 8455936
    [Abstract] [Full Text] [Related]

  • 12. Sequence and characterisation of the RET proto-oncogene 5' flanking region: analysis of retinoic acid responsiveness at the transcriptional level.
    Patrone G, Puliti A, Bocciardi R, Ravazzolo R, Romeo G.
    FEBS Lett; 1997 Dec 08; 419(1):76-82. PubMed ID: 9426223
    [Abstract] [Full Text] [Related]

  • 13. Isolation of ret proto-oncogene cDNA with an amino-terminal signal sequence.
    Takahashi M, Buma Y, Hiai H.
    Oncogene; 1989 Jun 08; 4(6):805-6. PubMed ID: 2660074
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A 5'-CG-3'-rich region in the promoter of the transcriptionally frequently silenced RET protooncogene lacks methylated cytidine residues.
    Munnes M, Patrone G, Schmitz B, Romeo G, Doerfler W.
    Oncogene; 1998 Nov 19; 17(20):2573-83. PubMed ID: 9840920
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Identification of the product of two oncogenic rearranged forms of the RET proto-oncogene in papillary thyroid carcinomas.
    Lanzi C, Borrello MG, Bongarzone I, Migliazza A, Fusco A, Grieco M, Santoro M, Gambetta RA, Zunino F, Della Porta G.
    Oncogene; 1992 Nov 19; 7(11):2189-94. PubMed ID: 1437145
    [Abstract] [Full Text] [Related]

  • 20. A RING finger motif regulates transforming activity of the rfp/ret fusion gene.
    Hasegawa N, Iwashita T, Asai N, Murakami H, Iwata Y, Isomura T, Goto H, Hayakawa T, Takahashi M.
    Biochem Biophys Res Commun; 1996 Aug 14; 225(2):627-31. PubMed ID: 8753810
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.